Johns Hopkins researchers report concrete steps in the use of human stem cells to test how diseased cells respond to drugs. Their success highlights a pathway toward faster, cheaper drug development for some genetic illnesses, as well as the ability to pre-test a therapy's safety and effectiveness on cultured clones of a patient's own cells. The project, described in an article published on the website of the journal Nature Biotechnology, began several years ago, when Gabsang Lee, D.V.M., Ph.D...
More...
More...